International Journal of Genetic Science

Dr. Raj Kumar is currently a Professor of Biochemistry at The Commonwealth Medical College (TCMC), Scranton, PA, USA. He received his Ph.D from University of Lucknow, India, and post doctoral training at University of Texas Medical Branch (UTMB), Galveston, USA. Before moving to TCMC, he held position of Associate Professor in the Department of Internal Medicine at UTMB. His current area of research is focused on the role of intrinsically disordered activation domain of transcription factors in the gene regulation. He serves as an editorial board member of about a dozen other international peer reviewed journals, and has served as scientific reviewer for more than 40 peer-reviewed journals. He has also served on numerous national and international scientific review panels. He has over 90 publications including peer-reviewed scientific journals, a book and several book chapters and a patent, and has been invited to speak at several international scientific meetings and research institutes/universities.

• Protein structure and functions
• Macromolecular interactions
• Cell signaling and Gene regulation
• Steroid hormone receptors
• Post translational modifications
• Neurodegenerative diseases
• Structure-based drug discovery

Dr. QianhongLi is an Associate Professor of Medicine in the Division of Cardiovascular Medicine at University of Louisville. She has been Director of Gene Therapy Core , Stem Cell and Pathology Core at the same university since 2005 and Director of Biomarker Core in the NIH Caesar. In these capacities, she has been directing two vigorous research laboratories and investigating the mechanisms responsible for myocardial ischemia / reperfusion injury and developing the cardioprotective strategies in the fields of gene therapy and stem cell therapy for many years. She is a recipient of two NIH grants and several regional grants. She has been a member of the Council on Basic Cardiovascular Sciences of the American Heart Association (AHA), of the International Society for Heart Research, and of the American Society of Gene & Cell Therapy for more than ten years. She is an international mentor in cardiovascular field elected by the American Heart Association. In 2011, she was elected as the Fellow of the national AHA (FAHA) because of her major and productive contributions to cardiovascular basic sciences. As a pioneer in this area, she has created and established an adult cardiac stem cell system in the mouse which possesses more than 30 adult cardiac stem cell populations and has been funded by the NIH.  

• Adult cardiac stem cell therapy for cardiac regeneration
• Gene therapy for myocardial injury
• Molecular mechanisms of ischemia and reperfusion injury
• Ischemic preconditioning in myocardium 

Dr. Ivona Percec is an Assistant Professor in the Division of Plastic Surgery at Perelman School of Medicine at the University of Pennsylvania in Philadelphia, PA. She completed her undergraduate work in Molecular Biology and Medieval History at Princeton University. She obtained her medical degree and doctorate in genetics from the Medical Scientist Training Program (MSTP) at the Perelman School of Medicine at the University of Pennsylvania. She completed her residency training in Plastic Surgery in the Division of Plastic Surgery at the University of Pennsylvania. she joined as Faculty of the Division of Plastic Surgery at the University of Pennsylvania. She is dedicated to the advancement of the translational science of aging through the study of primary human adipose tissue. 

• Investigate the function of the Sirtuin genes 
• Epigenetic modifications 
• Tissue harvest and preparation

Dr. Wei Li has received college education in Biology from Xinjiang University, China. He received phd in 1991 from the Department of Developmental Biology and Cancer at the Albert Einstein College of Medicine, Bronx, New York City. Following a two-year post-doctoral/instructor fellowship in the Department of Pharmacology at New York University Medical Center, he joined the faculty of the Ben May Institute for Cancer Research at the University of Chicago in the fall of 1993 as an Assistant Professor, with joint appointments in the Department of Pharmacological and Physiological Sciences and the Cancer Center. His research programs started receiving national funding from the American Cancer in 1994 and NIH funding from NCI in 1995. His teaching (16 hours/semester) at the University of Chicago was at graduate school levels. He came to University of Southern California (USC) as an Associate Professor in Division of Dermatology within the Department of Medicine in the beginning of 1999. At USC, he rose to full professor in 2006. He is currently a Director of Genetics, Molecular & Cell Biology (GMCB) graduate program department of Dermatology and USC-Norris Comprehensive Cancer Center in the University of Southern California, Keck Medical Center, USA.

• Signal transduction (growth factors and oncogenes)
• Molecular mechanisms of skin wound and healing cancer progression

Dr Abbas Amini is an assistant professor at the Australian College of ACK and Western Sydney University, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences. 

Bionanotech

Juergen Reichardthas a long and distinguished career in gene discovery and, more recently the functional assessment of DNA variants.  Examples of these include: cloning of the gene for classic galactosemia encoding galactose-1-phosphate uridyl transferase (GALT) with Nobel-prize winner Paul Berg in 1988 at Stanford. Reporting the first galactosemia mutations with Savio Woo in 1991 while at Baylor. Cloning the human gene for epimerase-deficiency galactosemia (UDP-glucose 4’ epimerase; GALE) in 1995. Reporting the first association between genetic variants in the human steroid 5a-reductase type II (encoded by the SRD5A2 gene) and prostate cancer in 1999. He identified and characterized significant biochemical and pharmacogenetic variation in human steroid 5a-reductase type II (encoded by the SRD5A2 gene) in 2000. He also discovered common somatic mutations in prostate cancer in the human steroid 5a-reductase type II (SRD5A2) gene in 2004. He was on the faculty at USC (the University of Southern California) for 13 years.  Juergen arrived in 2005 in Australia as the Plunkett Chair of Molecular Biology (Medicine) in Sydney where he continued many of his investigations as well as branching out into new areas by establishing new collaborations in Australia particularly in relationship to complex genetic traits, especially heart disease. Juergen was the Head of School, Pharmacy and Molecular Sciences at James Cook University. Furthermore, he has served as the Associate Dean Research for the Faculty of Medicine, Health and Molecular Sciences at James Cook University. In January 2016, Juergen took up the position of Vice Chancellor, Research and Innovation at YachayTech University in Ecuador, the first research-intensive university in Latin America which is modelled on CalTech. Juergen Reichardt has coauthored some 150 peer-reviewed publications with some 4,600 citations. Furthermore, he has held uninterrupted external funding for some 20 years on two continents. He also serves on the Council of HuGO, the Human Genome Organization, the International Scientific Advisory Committee (ISAC) of the Human Variome Project (HVP) and the Scientific Advisory Council of the Golden Helix Foundation. Juergen has co organized various international meetings, incl. the HGM 2012 (Human Genome Meeting 2012 in Sydney; Australia) and a series of PacRim Breast and Prostate Cancer Meetings in 3 different countries, he was a visiting professor at many universities, incl. Rome in 2013 and serves also on ten international editorial boards. Finally, he has lived in seven countries on four continents bringing a truly international perspective to his endeavours.

• Prostate cancer
• Glioblastoma
• Melanoma and atherosclerosis

Dr Jenny Y Wang is a Senior Lecturer at the Faculty of Medicine, University of New South Wales, and a Group Leader of Cancer and Stem Cell Biology at the Children’s Cancer Institute Australia for Medical Research, Sydney, Australia.  She received her phd in Molecular Biology and Biochemistry from Macquarie University, Sydney, Australia, and undertook postdoctoral training in cancer stem cell biology at Harvard Medical School /Harvard Stem Cell Institute in Boston, USA (2005 - 2011). Since relocating from the USA in June 2011 she has established an independent research group and received a number of national competitive grants. Research in Dr Wang's laboratory is focused on  (1) better understanding the cellular and molecular mechanisms by which genetic and epigenetic events are required for transforming normal stem/progenitor cells into aberrant stem cells, (2) identifying novel tumour-specific genetic and/or epigenetic genes and pathways, (3) investigating the delicate interplay between oncogenic pathways in leukaemia stem cells, and (4) studying the interactions between the bone marrow microenvironment (or niche) and normal/abnormal blood stem cells for developing a comprehensive understanding of complex disease processes. The ultimate goal of these studies is to develop cancer stem cell-targeted therapies that are more effective and less toxic for patients with tumours. 

• Cancer and Stem Cell Biology
• Cancer Genetics and Epigenetics
• Cell Signaling and Gene Regulation
• Tumor Microenvironment and targeted therapies 

Dr. Jean-François (Jeff) Picimbon completed his doctorate in Neurosciences-Neurobiology at the University of Provence (Aix Marseille I) in 1995 after graduated studies in Physiology-Neurophysiology at St Jérôme (Aix Marseille III) in France. His original work dealt with pheromone identification, regulation and perception in moths (CNRS-INRA French Ministry of Research MRE#92114-9210 MR/MFP 907). After further behavioral, chemical, molecular and physiological study of insect pheromones in Canada, Japan and USA, he joined the Institute of Physiology in Hohenheim University as Alexander von Humboldt fellow (molecular basis of insect olfaction) before to be appointed “Forskarassistent” (Assistant Professor) at the Department of Ecology from Lund University in Sweden (Ranked first). In 2001, his work on insect chemosensory proteins (CSPs) was honored as “one of the top ten most talented international young scientists” (14th NAITO Conference, Bioactive Natural Products and their Mode of Action, Kanagawa, Japan) for the report of moth and locust chemosensory proteins. In Lund, he led research on termite caste-specific genes (CYP genes), ECB moth male pheromone identification, chemical ecology, genetic, hormonal and endocrine regulation of pheromones, evolution of noctuid pheromone binding protein genes, genetics of insect chemosensing and basics of CSP protein structure and function with connection to CTBA-France (Bordeaux), INRA-France (Angers), School of Functional Genomics and Bioinformatics-Sweden, National Centre for Biomolecular Research at Mazaryk University-Czech Republic (Brno), Department of Biochemistry and Structural Biology (Lund) and various academic exchange/research programs from Belgium, Czech Republic, France, Lithuania and Sweden (Crafoordska Stiftelsen, Lund-Erasmus/Socrates grant programme, Swedish Research Council and Swedish Institute in Stockholm; Principal Investigator for research, principal lecturer and organizer, development of new course and programme between LU and EU). Dr. Picimbon joined China in 2006 in the frame of United Kingdom-China Laboratory of Insect Biology (Nanyang, Henan Province). Following award of Taishan Scholar and Outstanding Scientist from Abroad (2009), he is now Distinguished Professor at the School of Bioengineering at QILU University of Technology (QLUT) and Director of the Institute of Agricultural Microbiology in Jinan (Shandong Province, P.R. China). With Prof. Dr. Shousong Yue (SAAS), he aims at the development of new bio-natural microbial medicine for human health and other natural bio-potion for intensive animal farming or industrial livestock production (cure of piglet diarrhea). In addition of France-China cooperation, he also helps internationalization and English Development for Higher Education in China through teaching “Advanced Scientific English-Science” and “Frontiers of Science”: Evolution & Ecology, Animal Interactions, Pheromones, Neurobiology of Olfaction and Taste, at academic, university, college, junior secondary middle school and public audience. Dr. Picimbon (Jie Fu) serves as Associate Editor of Gene, Agri-Gene, International Journal of Bioorganic Chemistry and Molecular Biology, Journal of Clinical & Experimental Pathology and SOJ Microbiology and Infetctious Diseases, Journal of Clinical Pathology & Laboratory Medicine and International Journal of Proteomics & Genomics and also he is an Editor of "Olfactory Concepts of Insect Olfaction-Alternative to Insecticide" (Springer Nature). He is the Editor-in-Chief of Gene & Translational Bioinformatics (Smart Science & Technology, Houston, USA).

He is matter of several biographical records including Prabook and “Who is Who in Science and Bioengineering” (insect pheromones and chemosensory proteins). He is also Publons Peer Review Award  (top 1% of referees, USA) and Insect Science Most Cited Paper Award of 2017. Besides science, he is a member of dozen international societies and governmental institutions, before all France’s permanent representative to Shandong Province as ilot.SD@pekin-phedre.org in North-East Peninsula, North Yellow Sea, P. R. China

• Natural Traditional Biomedicine
• Neurobiology, Genetic and Molecular Biology of Olfaction
• Evolution and Evolutionary Genomics

Dr Tao Liu is a medical practitioner specializing in neurology, studied for a PhD degree at The University of New South Wales, Sydney, Australia on the role of inflammatory mediators in chronic pain due to nerve injury. He then worked on the role of MIC-1, a new member of the transforming growth factor beta superfamily, in cancer cell proliferation, survival/apoptosis and metastasis at St. Vincent's Centre for Applied Medical Research, Sydney, Australia. He joined Children's Cancer Institute Australia for Medical Research as a Senior Research Officer in 2003. Since 2004, he has been focusing his research on the roles of histone deacetylases, histone demethylases, histone methyltransferases and long noncoding RNAs in modulating gene transcription and tumourigenesis, and the roles of histone deacetylase inhibitors and histone methyltransferase inhibitors as anticancer agents. He was promoted to Project Leader in 2009 and Group Leader in 2011.

• Molecular and cellular biology
• Chromatin modification
• Gene transcription, genomics and epigenetics
• Drug discovery and Experimental cancer therapy

Dr. Madhusudhanan Narasimhan is a senoir research associate in the department of Pharmaology and neuroscience in Texas Tech University Health Science Centre. He is a member of Sigme Xi.  He received his PhD in Biochemistry, University of Madras, India (1999-2003). He is an expert in dissecting the multiple signaling events and assessing the therapeutic benefits of natural compounds, synthetic compounds, antisense oligonucleotides, microRNAs, nanoparticle loaded siRNA in various cancer background using range of cancer cell lines (breast, prostate, leukemia, lung, ovarian, neuroblastoma, glioma). Experienced in gene regulation based studies to explore neurotoxicological and neurodevelopmental abnormalities using primary astrocytes, neurons, in utero and early postnatal rat models.  Skilled in designing experiments, executing, analyzing the data with extensive presentation experience at scientific conferences. He  has nearly 20 publications and has given more than 30 presentations.

• Multiple signaling events 
• Assessing the therapeutic benefits of natural compounds in cancer therapy
• Gene regulation based studies 

Dr. Valentina Echeverria Moranis is a scientist at VA Healthcare System. She received her post doctoral from Johns Hopkins Univeristy. She acquired a broad and in-depth background of the molecular mechanisms of memory and experience in translational research using animal models of cognitive impairment. As a postdoctoral fellow at McGill, she carried out studies of molecular mechanisms of memory loss using rat models of Alzheimer’s disease. At the Johns Hopkins University, she worked with animal and cellular models of neuroinflammation including Alzheimer’s disease and stroke. At Columbia University in New York, she continued investigating pathological mechanisms involved in memory loss in Alzheimer’s disease. As a principal investigator at Bay Pines Veterans Affairs Medical Center in Florida, she expanded her area of research to cognitive changes associated with anxiety disorders. As PI on several previous University-Foundations, NIH-Sub award, Alzheimer’s association and Department of Health of Florida -funded grants, she also discovered and characterizing a new cognitive enhancer antidepressant and anxiolytic compound named Cotinine. In this position she managed six research grants and personnel, published numerous articles and obtained 3 provisional patents. She also worked with international and national collaborators and presented in numerous national and international professional meetings in biomedicine. She has many professional associations which include American Society for Neurosciences, New York Academy of Sciences. She has 30 scientific publications.

• Translational research
• Study of cognitive changes associated with anxiety disorders.

Dr. Yunfeng Lin is Professor of State Key Laboratory of Oral Diseases, Sichuan University. He serves as the Vice-director of State Key Laboratory of Oral Diseases and Assistant Dean of West China School of Stomatology. He received his Ph.D. from Sichuan University in 2006. His research focus on adipose stem cells differentiation and craniofacial regeneration, such as bone, cartilage, tooth, fat et al. He has published over 60 papers, reviews and book chapters, and made several seminal contributions to the stem cells fields. He received New Century Excellent Talents of Chinese Ministry of Education and National Excellent Doctoral Dissertation of China.

• Stem cells
• Tissue engineering and regenerative medicine

Dr. Odanir Garcia War is currently a Associate Professor with acting courses : Degree in Biological Sciences and Nursing "Federal University of Mato Grosso do Sul" Três Lagoas Campus/MS - Brazil, which operates in the areas of teaching, research and extension and academic tutor undergraduate research and scholarship remainedis. He graduated in Biomedicine from the Faculty of Philosophy, Sciences and Letters "Barão de Mauá" - Ribeirão Prêto / SP - Brazil (1981), Bachelor of Science (1986), with specialization in Biology (1987) from the "Federal University of Mato Grosso do Sul" - Três Lagoas / MS - Brazil, Degree in Biological Sciences "Federal University of Mato Grosso do Sul" - Três Lagoas / MS - Brazil (1993). As Public Health Specialist - Sanitarian, from the National School of Public Health, "Oswaldo Cruz" - Rio de Janeiro / RJ, Brazil (1989). He did Masters in Biotechnology "University of São Paulo" São Paulo / SP - Brazil (2002) and a phd in Sciences - Microbiology from the “University of São Paulo" São Paulo / SP - Brazil (2006).

• Microliologia
• Genetic Engineering
• Molecular Genetics of microorganisms
• Public Health,  epidemiology 

Dr. Tibor Valyi-Nagy is a Professor of Pathology and Director of Neuropathology at the University of Illinois at Chicago. He received his clinical and research training at the Medical University of Debrecen, Hungary, University of Texas Medical Branch at Galveston, The Wistar Institute of Philadelphia and Vanderbilt University.

• Pathogenesis of nervous system infections
• Viral oncolytic therapy

Dr PatsiePolly is a Senior Lecturer and Group Leader of the Cancer Cachexia Mechanisms Research Group, with particular expertise in gene regulatory mechanisms underlying muscle wasting due to cancer cachexia. She has developed gene and proteomic approaches for identifying biomarkers in skeletal muscle wasting and has extensive experience with molecular and cellular techniques required to study molecular mechanisms of transcription factor-mediated gene regulation. Polly’s specific expertise is in unraveling mechanisms that involve DNA-protein interactions and protein-protein interactions. Her expertise was key in a collaborative capacity (Cancer Cell, 16/08/2011) where a potential paradigm shift in understanding methylation at promoter sites also responsible for binding transcription factors was reported. She has previously established research programs on molecular mechanisms of nuclear receptor (Alexander von Humboldt Fellow) and myogenic transcription factor action (NHMRC Howard Florey Fellow and JSPS Fellow). She is one of the first to publish on VDR-Co-repressor mediated transcriptional mechanisms in the field of Vitamin D regulation. She has published 54 peer-reviewed papers and received $9.74 million in grant funding. She has been cited >610 times and has an H-factor=13 (Scopus). Polly has supervised 17 Honours (14-1st class, 3-2nd class division 1), 1 Medical ILP research intern, 1 Research Intern and 6 phd students. Polly has been recognized with 7 UNSW and National awards. She has attracted $5.045 million in teaching research funding.

• DNA-protein interactions and protein-protein interactions
• Binding mechanisms of transcirption factors

Dr. Farid Menaa holds phd in Radiation Oncology and Gerontology, three international post-doctoral terms, EMBA Entrepreneurship and MD candidate), he is an experienced and skilled inter-and multi-disciplinary professional. He is a Professor, Consultant, Researcher, Principal Investigator, Executive Director, Advisor, Editor, Reviewer, Event Organizer and Entrepreneur and earned his degrees with high distinctions from prestigious universities and institutions. After he is distinguished doctoral thesis in gerontology/geriatry and oncology from Sorbonne /Jussieu University & Nuclear Energy Authority (Paris, France, 1999-2003), he was selected as a NIH post-doctoral fellow in Oncology (San Diego, California, USA; 2004-2007). Then, he pursued his career in dermatology, and Stem Cells as a DFG post-doctoral Fellow (Wuerzburg, Germany; 2007-2009). Subsequently, he was promoted to Chief Scientific Officer and Executive Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. He was appointed as Principal Invesgator in Hematology and Genomics as a FAPESP post-doctoral Fellow (São Paulo, Brazil; 2010-2012. Dr. Menaa is, among others, the leading organizer of the “Target Meeting ́s 1st World Nanomedicine and Nanobiotechnology Online Conference ” (http://www.targetmeeting.com; 2013), member of thetechnical committee of a large number of international scientific events, member of several prestigious medical and scientific organizations (>10). Dr. Menaa is further the editor, guest editor and reviewer of a large number of esteemed journals worldwide (>50). 

• Oncology
• Gerontology
• Genetics
• Biochemistry, Cell and Molecular Biology
• Nanobiotechnology and Nanomedicine

Dr. Anirban K Mitra is currently an Assistant Professor of Medical and Molecular Genetics in the Medical Sciences Program of Indiana University School of Medicine, Bloomington, Indiana. He did his MS in Biotechnology from Devi Ahilya University in Indore, India and completed his Ph.D. in Biochemistry from the University of Mumbai in Mumbai, India. Thereafter, he recieved his postdoctoral training under the mentorship of Dr. Ernst Lengyel in the Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago, Chicago. 

• Role of microRNAs in ovarian cancer metastasis
• Interactions between cancer cells in ovarian cancer

Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Netherlands, Russia, France, Swiss, Germany, Sweden, Italy, Spain, Portugal, Mexico, Taiwan, South Korea, China, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books in Chemistry. Syne, he has been awarded more than four hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals. Hitherward, he is a member of more than one hundred reputed international academic–scientific–research institutes around the world.

·         Quantum Chemistry

·         Nanochemistry

·         Theoretical Chemistry

·         Mathematical Chemistry

·         Computational Chemistry

·         Vibrational Spectroscopy

·         Molecular Modelling

·         Ab initio & Density Functional Methods

·         Molecular Structure

Dr. Miguel Burgos is a professor in the department of genetics at the university of Granada. He received his PhD form the same university in the year 1986. His professional career started with lecturership in the same university. He is also a member of Spanish Genetics Society Comitee since 2006. He has 77 scientific publications.

• Genetic control of sexual development

Dr. Alice Hudder is an Associate Professor of Biochemistry and Medical Genetics at the Lake Erie College of Osteopathic Medicine (LECOM) in Erie, Pennsylvania. She received her Ph.D. in Biochemistry and Molecular Biology from the University of Miami Miller School of Medicine where she investigated the regulation of expression of gap junction proteins in the nervous system. Her postdoctoral work in the laboratory of Dr. Murray Deutscher at the University of Miami Miller School of Medicine focused on protein-protein interactions in mammalian cell cytoplasm. This was followed by an Associate Scientist position at University of Miami Rosenstiel School of Marine and Atmospheric Sciences where she worked on the transcriptome of the popular neuroscience model organism, Aplysia. After that she was recruited to Wayne State University’s Institute of Environmental Health Sciences, where she was an Assistant Professor. During this time she developed independent and collaborative research projects in several areas including: examining the effects of heavy metals on insulin signaling and gene expression in rat liver;examining the effects of elevated atmospheric CO2 on gene expression in cyanobacteria; development of a  high-throughput assay to study toxic effects on gap junctional communication; and development of a device to be used onboard ships to verify ballast water decontamination procedures to help protect the Great Lakes environment. Since moving to LECOM, she has continued to make progress in these research areas while earning a Master’s degree in Medical Education from LECOM and working on research and development in methods of teaching and learning and their application to Genomics Education for Physicians. 

• Gene-environment interaction
• Role of regulatory RNAs in control of gene expression
• Whole genome sequence analysis and applications for medicine
• Educational strategies for adult learners

Prof. S.Panneerchelvam born on 28^th June, 1951 in a rural background completed M.Sc., Degree in the year 1974.  Worked in various positions in Forensic Sciences Department, Chennai India for 27 years rendering Forensic science service as crime scene investigator, analyst and teaching Biology, serology and Genetics to Forensic Science students.  Completed  Bachelor of Law degree in the year 1992 in the University of Madras. Continued to work as Senior Lecturer in the Universiti Sains Malaysia till 15^th March 2016 teaching Biology, Serology, Human Genetics, Molecular biology, Forensic DNA profiling techniques, Fire investigation. Published 26 research publications and 38 other publications. supervised Ph.D. and Master students on molecular genetics, DNA profiling and human genetics. Supervised many research grants. Received awards for teaching.Positions held Asst.director and Reader ,Forensic sciences Department, Govt.of Tamilnadu, Senior Lecturer in the department of School of  HealthSciences;Universiti Sains Malaysia.

• Molecular biology 
• Population genetics
• DNA profiling
• Sequence polymorphism –mt.DNA polymorphism
• HLA polymorphism for application in human  identification and in the study of prehistoric migration
• Barcoding of Wild life –species identification using molecular techniques

Prof Dr. Bernd Schierwater trained in Zoology by Carl Hauenschild and in Biochemistry by Fritz Wagner (both Technical University Braunschweig, Germany), in marine biology by Peter Frank (Woods Hole), in evolutionary theory by Leo Buss (Yale University, postdoctoral advisor), and in molecular genetics by Stephen Dellaporta (Yale University, postdoctoral and research associate advisor). His training in evolutionary genetics, ecological genetics and systems biology has arisen from running laboratories at Frankfurt University (Ass. Professor),Freiberg University (Assoc. Professor) and Hannover TiHo University (Full Professor) and from working as a Research Associate in the labs of Stephen Dellaporta (Yale) and Rob DeSalle (AMNH, New York). Taking advantage of my multi-disciplinary education I have developed the most primitive metazoan animals, the placozoans, into an emerging model system for biological research. He is having many grants (DFG SCHI, National Science Foundation, German Science Foundation, National Institute of Health, Human Frontier Science Program, BMBF Germany) and also 136 publications (Books and Volumes, Selected Review Articles, Book Chapters and Short Communications)

Evolutionary Genetics of Placozoa, Biomedical Approaches to Human Health

Dr Edinur Hisham Atanis a Lecturer at Universiti Sains Malaysia (USM), Malaysia. He did  his BSc in Forensic Science from USM and completed MSc in Forensic DNA from USM,and PhD in Cell and Molecular Bioscience from Victoria University, New Zealand. He is a Fellow of the ASEAN Science Leadership Program, Asian Council of Science and Editors & Member of Forensic Science Society of Malaysia. He is having 34 publications (books, chapter in the books, articles,conference proceedings etc). His research has focused on using new and existing molecular technologies to survey immune systems (i.e. HLA, KIR, cytokine and MICA), blood group, HNA and HPA genes in several populations including Polynesians, Orang Asli and Malays. The data collected have significant value in ancestry and health including tissue matching for transfusion and transplant surgery, disease resistance and the relative incidence of autoimmune disease in these populations. He is now extending the genetic screening work to several sub-populations in Borneo (e.g Kadazan, Iban, Melanau, Kedayan, Bajau and Murut) and Ghana and have also proposed several studies to search for candidate genes associated with autoimmune diseases in Malaysian sub-populations. The previous and existing genetic screening programs have been funded by local and international grants.

• Molecular biology

• Population genetics

• Immunogenetics

• Forensic DNA

• Development of viral as well as non-viral strategies for systemic in vivo delivery of siRNA, miRNA,

• Antisense oligonucleotides, CRISPR/Cas9 gene-editing and gene-replacement tools to treat Neuromuscular diseases.